09:00 a.m. 10:30 a.m. |
•
•
• |
ACADEMIC SESSION 2 Residual risk: macrovascular risk in type II diabetes Chair: Sacks Frank (USA) Atherogenic dyslipidemia: components and actors in CVD Sacks Frank (USA) Non-LDL - Related dyslipidemia and coronary risk Assmann Gerd (Germany) Macrovascular residual risk reduction in patients with type II diabetes Fruchart Jean-Charles (France) |
10:30 a.m. 11:00 a.m. |
 |
Coffee break |
11:00 a.m. 12:30 p.m. |
•
•
• |
Academic Session 3 Residual risk: microvascular risk in type II diabetes Chair: Fioretto Paola (Italy) Residual risk of microvascular complications of diabetes: focus on nephropathy Fioretto Paola (Italy) Residual risk of microvascular complications of diabetes: focus on retinopathy Facsko Andrea (Hungary) Macrovascular and Microvascular residual risk reduction: current limitations and insights into the future Keech Anthony (Australia) |
12:30 p.m. 02:00 p.m. |
•
•
• |
Lunch Symposium sponsored by KOWA Importance of HDL-C Chair: Chapman M. John (France) HDL particles, metabolism and cardiovascular disease Schaefer Ernst J. (USA) Mechanisms and clinical significance of HDL - C elevation by statins Chapman M. John (France) Clinical impact on cardiovascular risk of low HDL - C Farnier Michel (France) |
02:00 p.m. 03:30 p.m. |
•
•
• |
Academic Session 4 Post-prandial lipemia and cardiovascular risk Chair: Assmann Gerd (Germany) Fasting or postprandial triglyceridemia: review of the evidence and future directions Rosenson Robert S. (USA) Mechanisms of postprandial inflammation in relation to atherosclerosis: triglycerides or glucose ? Castro Cabezas Manuel (The Netherlands) The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment Ordovas Jose (USA) |
03:30 p.m. 04:00 p.m. |
|
Coffee break |
04:00 p.m. 05:30 p.m. |
•
•
• |
Symposium sponsored by NOVARTIS PHARMA Management of cardiovascular diseases: evolution of new practices ? Chair: Dubois Claude (France) From hypertension to heart failure :The interest of ARBs Galinier Michel (France) Renin-angiotensin system: new therapeutic approaches ? Vaisse Bernard (France) News regarding the management of type II diabetes Huet Dominique (France) |
Program |
Partnership |
Call to |
